open access

Vol 13, No 1 (2007)
Original papers
Published online: 2007-04-16
Get Citation

The influence of oral supplementation of L-arginine on intermittent claudication in patients with peripheral arterial disease of the lower extremities

Maciej Micker, Hanna Krauss, Jarosław Ast, Paweł Chęciński, Anna Jabłecka
Acta Angiologica 2007;13(1):1-14.

open access

Vol 13, No 1 (2007)
Original papers
Published online: 2007-04-16

Abstract


Background. More and more data indicate that the increase of production of free radicals by the endothelium with simultaneously decreasing synthesis and/or increasing nitric oxide (NO) degradation is the basis of changes in atheromatous vessel structure and reactivity. It is suggested that the administration of L-arginine to patients with NO deficiency is the rational method both of increasing NO production by the endothelium and decreasing the free radical release. In the last year it has been proven that this therapeutic procedure could be successful in patients with atherosclerotic ischaemia of lower extremities. The aim of this study was the estimation of the influence of 28-day L-arginine oral supplementation on intermittent claudication in patients with peripheral arterial occlusive disease.
Material and methods. The authors studied 48 patients (25 men/23 women) with peripheral arterial disease - Fontaine II. They were randomly divided into two groups: group I - 24 patients receiving L-arginine 3 × 4 g/day and group II - 24 patients receiving placebo 3 × 4 g/day. During the study patients were under strict clinical observation, the aim of which was to evaluate drug tolerance and to observe possible adverse effects of L-arginine used in therapy. During the study at 0 h, after 3 h, and on the 7th, 14th, and 28th days subjective and objective examinations were conducted with evaluation of pain-free distance and total walking distance.
Results. After L-arginine treatment clinical improvement was observed in all patients, such as elongation of pain-free walking distance (from 80 m at the beginning to 438 m at the end) and total walking distance (from 158 m to 687 m), while there was no clinical improvement in patients with placebo.
Conclusions. In patients with peripheral arterial occlusive disease Fontaine stage II oral supplementation of L-arginine results in elongation of pain-free and total walking distance.

Abstract


Background. More and more data indicate that the increase of production of free radicals by the endothelium with simultaneously decreasing synthesis and/or increasing nitric oxide (NO) degradation is the basis of changes in atheromatous vessel structure and reactivity. It is suggested that the administration of L-arginine to patients with NO deficiency is the rational method both of increasing NO production by the endothelium and decreasing the free radical release. In the last year it has been proven that this therapeutic procedure could be successful in patients with atherosclerotic ischaemia of lower extremities. The aim of this study was the estimation of the influence of 28-day L-arginine oral supplementation on intermittent claudication in patients with peripheral arterial occlusive disease.
Material and methods. The authors studied 48 patients (25 men/23 women) with peripheral arterial disease - Fontaine II. They were randomly divided into two groups: group I - 24 patients receiving L-arginine 3 × 4 g/day and group II - 24 patients receiving placebo 3 × 4 g/day. During the study patients were under strict clinical observation, the aim of which was to evaluate drug tolerance and to observe possible adverse effects of L-arginine used in therapy. During the study at 0 h, after 3 h, and on the 7th, 14th, and 28th days subjective and objective examinations were conducted with evaluation of pain-free distance and total walking distance.
Results. After L-arginine treatment clinical improvement was observed in all patients, such as elongation of pain-free walking distance (from 80 m at the beginning to 438 m at the end) and total walking distance (from 158 m to 687 m), while there was no clinical improvement in patients with placebo.
Conclusions. In patients with peripheral arterial occlusive disease Fontaine stage II oral supplementation of L-arginine results in elongation of pain-free and total walking distance.
Get Citation

Keywords

L-arginine; NO; intermittent claudication

About this article
Title

The influence of oral supplementation of L-arginine on intermittent claudication in patients with peripheral arterial disease of the lower extremities

Journal

Acta Angiologica

Issue

Vol 13, No 1 (2007)

Pages

1-14

Published online

2007-04-16

Bibliographic record

Acta Angiologica 2007;13(1):1-14.

Keywords

L-arginine
NO
intermittent claudication

Authors

Maciej Micker
Hanna Krauss
Jarosław Ast
Paweł Chęciński
Anna Jabłecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl